Form 4 for TVRD Tvardi Therapeutics, Inc.
Accepted 2022-12-23 00:00:00 ET · period of report 2022-12-21 · accession 0001209191-22-062632 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-23 | 2022-12-21 | TVRD | Menzaghi Frederique Ph.D. | Chief Scientific Off, SVP-R, D | S - Sale | $11.27 | -3,506 | 166.3K | -2% | -$39.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-21 | S | D | 3,506 | $11.27 | 166,275 | D | — | — |